Lipids and vascular disease: A Framingham perspective

Global Heart

Volumn 8, Issue 1, 2013, Pages 25-33

  Wilson, Peter W F ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

BODY MASS; CARDIOVASCULAR DISEASE; GENETICS; HEART DISEASE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; PARTICLE SIZE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SELF REPORT; ULTRACENTRIFUGATION; VASCULAR DISEASE;

EID: 84875164052     PISSN: 22118160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gheart.2012.12.009     Document Type: Review

References (56)

1. L.L. Abell, B.B. Levy, B.B. Brodie, and F.E. Kendall A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity J Biol Chem 195 1952 357 366
2. G. Kessler, and H. Lederer Automation in Analytical Chemistry, Technicon Symposia 1965 1st edition. 1965 Mediad Inc. New York, NY
3. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular risk factors: the Framingham study Circulation 59 1979 8 13
4. Evaluation of serum lipoprotein and cholesterol mesurements as predictors of clinical complication of atherosclerosis: report of a cooperative study of lipoproteins and atherosclerosis Circulation 14 1956 691 742
5. W.B. Kannel, W.P. Castelli, T. Gordon, and P.M. McNamara Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham study Ann Intern Med 74 1971 1 12
6. W.B. Kannel, T.R. Dawber, A. Kagan, N. Revotskie, and J. Stokes 3rd Factors of risk in the development of coronary heart disease - six year follow-up experience: the Framingham study Ann Intern Med 55 1961 33 50
7. D.S. Fredrickson, R.I. Levy, and R.S. Lees Fat transport in lipoproteins - an integrated approach to mechanisms and disorders N Engl J Med 276 1967 94 103
8. Lipid Research Clinics Program. Manual of Laboratory Operation 1st edition. 1974 National Institutes of Health Bethesda, MD
9. L.I. Gidez, G.J. Miller, M. Burstein, S. Slagle, and H.A. Eder Separation and quantitation of subclasses of human plasma high densitylipoproteins by a simple precipitation procedure J Lipid Res 23 1982 1206 1233
10. G. Heiss, I. Tamir, and C.E. Davis Lipoprotein-cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study Circulation 61 1980 302 315
11. J.F. Brensike, R.I. Levy, and S.F. Kelsey Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study Circulation 69 1984 313 324
12. A.G. Bostom, D.R. Gagnon, and L.A. Cupples A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study Circulation 90 1994 1688 1695
13. A.M. Scanu, and L. Scandiani Lipoprotein(a): structure, biology, and clinical relevance Adv Intern Med 36 1991 249 270
14. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease: the Framingham study Am J Med 62 1977 707 714
15. G.J. Miller, and N.E. Miller Plasma-high-density-lipoprotein concentration and development of ischemic heart disease Lancet 1 1975 16 19
16. Summary of the second report of the National Cholesterol Education Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA 269 1993 3015 3023
17. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Arch Intern Med 34 1988 193 201
18. R.J. Garrison, P.W. Wilson, W.P. Castelli, M. Feinleib, W.B. Kannel, and P.M. McNamara Obesity and lipoprotein cholesterol in the Framingham offspring study Metabolism 29 1980 1053 1060
19. S. Lamon-Fava, D. Jimenez, and J. Christian The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and condordance for lipoprotein (a) Atherosclerosis 91 1991 97 106
20. K.M. Anderson, P.W. Wilson, R.J. Garrison, and W.P. Castelli Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample: the Framingham Offspring Study Atherosclerosis 68 1987 59 66
21. H. Campos, P.W.F. Wilson, D. Jimenez, J.R. McNamara, J. Ordovas, and E.J. Schaefer Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study Metabolism 39 1990 1033 1038
22. S.M. Vaziri, J.C. Evans, M.G. Larson, and P.W. Wilson The impact of female hormone usage on the lipid profile: the Framingham Offspring Study Arch Intern Med 153 1993 2200 2206
23. R.D. Siegel, A. Cupples, E.J. Schaefer, and P.W. Wilson Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham Offspring Study Metabolism 45 1996 1267 1272
24. A.L. Dannenberg, J.B. Keller, P.W. Wilson, and W.P. Castelli Leisure time physical activity in the Framingham Offspring Study: description, seasonal variation, and risk factor correlates Am J Epidemiol 129 1989 76 88
25. R.J. Garrison, W.B. Kannel, M. Feinleib, W.P. Castelli, P.M. McNamara, and S.J. Padgett Cigarette smoking and HDL cholesterol: the Framingham Offspring Study Atherosclerosis 30 1978 17 25
26. K.J. Mukamal, P.P. Jadhav, and R.B. D'Agostino Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort Circulation 104 2001 1367 1373
27. P.W. Wilson Lipoprotein measurements - setting priorities Am J Med 110 2001 71 72
28. E. Ingelsson, E.J. Schaefer, and J.H. Contois Clinical utility of different lipid measures for prediction of coronary heart disease in men and women JAMA 298 2007 776 785
29. D.S. Freedman, J.D. Otvos, and E.J. Jeyarajah Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham study Clin Chem 50 2004 1189 1200
30. P.W. Wilson, R.H. Myers, M.G. Larson, J.M. Ordovas, P.A. Wolf, and E.J. Schaefer Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study JAMA 272 1994 1666 1671
31. P.W. Wilson, R.B. D'Agostino, H. Parise, L. Sullivan, and J.B. Meigs Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus Circulation 112 2005 3066 3072
32. J.B. Meigs, M.K. Rutter, L.M. Sullivan, C.S. Fox, R.B. D'Agostino Sr., and P.W. Wilson Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome Diabetes Care 30 2007 1219 1225
33. J.R. McNamara, H. Campos, J.M. Ordovas, J. Peterson, P.W. Wilson, and E.J. Schaefer Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study Arteriosclerosis 7 1987 483 490
34. H. Campos, J.R. McNamara, P.W. Wilson, J.M. Ordovas, and E.J. Schaefer Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women J Clin Endo Metab 67 1988 30 35
35. J.B. Meigs, P.F. Jacques, and J. Selhub Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study Diabetes Care 24 2001 1403 1410
36. J.B. Meigs, D.M. Nathan, P.W. Wilson, L.A. Cupples, and D.E. Singer Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study Ann Intern Med 128 1998 524 533
37. M.F. Hivert, L.M. Sullivan, and C.S. Fox Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance J Clin Endocrinol Metab 93 2008 3165 3172
38. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol In Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
39. A.G. Bostom, L.A. Cupples, and J.L. Jenner Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger: a prospective study JAMA 276 1996 544 548
40. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, and E. Steiner High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2001 2026 2033
41. P.J. Barter, C.M. Ballantyne, and R. Carmena Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel J Intern Med 259 2006 247 258
42. R.H. Myers, E.J. Schaefer, and P.W. Wilson Apolipoprotein E allele 4 is associated with dementia in the Framingham Study K. Iqbal, J.A. Mortimer, B. Winblad, H.M. Wisniewski, Research Advances in Alzheimer's Disease and Related Disorders 1st edition. 1995 Wiley New York, NY 63-70
43. R.H. Myers, E.J. Schaefer, and P.W. Wilson Apolipoprotein E epsilon4 asociation with dementia in a population-based study: the Framingham study Neurology 46 1996 673 677
44. S. Kathiresan, O. Melander, and D. Anevski Polymorphisms associated with cholesterol and risk of cardiovascular events N Engl J Med 358 2008 1240 1249
45. S. Kathiresan, K. Musunuru, and M. Orho-Melander Defining the spectrum of alleles that contribute to blood lipid concentrations in humans Curr Opin Lipidol 19 2008 122 127
46. S. Kathiresan, O. Melander, and C. Guiducci Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat Genet 40 2008 189 197
47. L.A. Cupples, H.T. Arruda, and E.J. Benjamin The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports BMC Med Genet 8 Suppl 1 2007 S1
48. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
49. K.M. Anderson, P.W. Wilson, P.M. Odell, and W.B. Kannel An updated coronary risk profile: a statement for health professionals Circulation 83 1991 356 362
50. K.M. Anderson, P.M. Odell, P.W. Wilson, and W.B. Kannel Cardiovascular disease risk profiles Am Heart J 121 1991 293 298
51. W.C. Cromwell, J.D. Otvos, and M.J. Keyes LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - implications for LDL management J Clin Lipidol 1 2007 583 592
52. D.M. Lloyd-Jones, P.W. Wilson, and M.G. Larson Lifetime risk of coronary heart disease by cholesterol levels at selected ages Arch Intern Med 163 2003 1966 1972
53. P.W. Wilson, J.M. Hoeg, and R.B. D'Agostino Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis N Engl J Med 337 1997 516 522
54. S. Lamon-Fava, P.W. Wilson, and E.J. Schaefer Impact of body mass index on coronary heart disease risk factors in men and women: the Framingham Offspring Study Arterioscler Thromb Vasc Biol 16 1996 1509 1515
55. R.D. Abbott, P.W. Wilson, W.B. Kannel, and W.P. Castelli High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham study Arteriosclerosis 8 1988 207 211
56. J.B. Meigs, R.B. D'Agostino Sr., P.W. Wilson, L.A. Cupples, D.M. Nathan, and D.E. Singer Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study Diabetes 46 1997 1594 1600